Methods For Screening For Mutations At Various Positions In The Introns And Exons Of The Cystic Fibrosis Gene

The Cystic Fibrosis Gene And Its Gene Product Are Described For Mutant Forms. The Genetic And Protein Information Is Used In Developing Dna Diagnosis, Protein Diagnosis, Carrier And Patient Screening, Cloning Of The Gene And Manufacture Of The Protein, And Development Of Cystic Fibrosis Affected Animals.

Patent Number: US5981178A
Application Number: US1995469461A
Inventor: Tsui, Lap Chee | Rommens, Johanna M. | Kerem, Bat sheva
Priority Date: 12 Jan 1990
Priority Number: US5981178A
Application Date: 6 Jun 1995
Publication Date: 9 Nov 1999
IPC Current: C07K001447 | C12N000115 | C12N000119 | C12N000121 | C12N001512 | C12N001585 | C12Q000168
US Class: 43500615 | 435006 | 435810 | 514851 | 53602431
Assignee Applicant: HSC Research Development Corporation,Toronto
Title: Methods for screening for mutations at various positions in the introns and exons of the cystic fibrosis gene
Usefulness: Methods for screening for mutations at various positions in the introns and exons of the cystic fibrosis gene
Novelty: Mutant cystic fibrosis trans-membrane conductance regulator gene used for producing prods. for diagnosis, screening and therapy of cystic fibrosis

Biomedical

DNA/Gene Engineering

US1995469461A

Hong Kong